Stimcell Energetics (STME) Profit After Tax Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Profit After Tax Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 15.14% |
| Nov 30, 2025 | -9.52% |
| Aug 31, 2025 | -0.58% |
| May 31, 2025 | -6.07% |
| Feb 28, 2025 | 16.74% |
| Nov 30, 2024 | 14.37% |
| Aug 31, 2024 | 23.31% |
| May 31, 2024 | 2.78% |
| Feb 29, 2024 | 18.11% |
| Nov 30, 2023 | 12.94% |
| Aug 31, 2023 | 20.52% |
| May 31, 2023 | 35.32% |
| Feb 28, 2023 | 18.66% |
| Nov 30, 2022 | 4.67% |
| Aug 31, 2022 | 28.59% |
| May 31, 2022 | 29.48% |
| Feb 28, 2022 | 15.49% |
| Nov 30, 2021 | 31.97% |
| Aug 31, 2021 | 8.89% |
| May 31, 2021 | -4.17% |